-
Price Momentum
STLN is trading near the top of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of STLN shares has increased $0.21 since the market last closed. This is a 3.33% rise.
-
Opened at $6.21.
The stock opened $0.09 lower than its previous close.
Key terms
About STLN
Starling Oncology, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
-
Market cap: $629.89M
A market capitalization between $300 million and $2 billion places STLN in the small capitalization category.
Key terms
Smart score
Latest STLN news
STLN Financials
-
Total revenue: $502.73M (1Y), $161.28M (Q2)
Total Revenue increased 27.79% since last year and increased 9.39% since last quarter.
-
Net income: -$50.30M (1Y), -$8.24M (Q2)
Net Income increased 5.09% since last year and decreased 293.55% since last quarter.
-
Earnings per share: -$0.54 (1Y), -$0.08 (Q2)
EPS increased 22.91% since last year and decreased 288.35% since last quarter.
Key terms
STLN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
STLN Competitors
-
How competitors are chosen
STLN's competitors are included in the Health Services sector and Medical/Nursing Services group
-
Market cap: $629.89M
A market capitalization between $300 million and $2 billion places STLN in the small capitalization category.
Key terms
Latest investing news
-
Bond market takes a breather after surprise move by Treasury Department -
Global bond markets are getting hammered. Here’s why that could make your life more expensive -
‘Brazen act of self-dealing.’ Lawmakers, watchdogs alarmed after Trump regulators let Trump firm start a bank -
The S&P 500 is back at a record high and the Dow just hit 54,000
